BerGenBio

AGM Information • Mar 9, 2018

BerGenBio ASA: Extraordinary general meeting

BerGenBio ASA: Extraordinary general meeting

Bergen, Norway, 9 March 2018 - an extraordinary general meeting of BerGenBio ASA was held in the Company's offices in Jonas Lies vei 91, 5009 Bergen, on 9 March 2018.

All proposals were resolved as presented in the notice convening the extraordinary general

meeting distributed on 16 February 2018, as further set out in the minutes from

the extraordinary general meeting attached hereto.

For further information, please contact:

Richard Godfrey

CEO, BerGenBio ASA

+47 917 86 304

Rune Skeie

CFO, BerGenBio ASA

rune.skeie@bergenbio.com

+47 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not

historical facts, but are based upon various assumptions, many of which are

based, in turn, upon further assumptions. These assumptions are inherently

subject to significant known and unknown risks, uncertainties and other

important factors. Such risks, uncertainties, contingencies and other important

factors could cause actual events to differ materially from the expectations

expressed or implied in this announcement by such forward-looking statements

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.